112 related articles for article (PubMed ID: 37580229)
21. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome is associated with and predicted by resting heart rate: a cross-sectional and longitudinal study.
Jiang X; Liu X; Wu S; Zhang GQ; Peng M; Wu Y; Zheng X; Ruan C; Zhang W
Heart; 2015 Jan; 101(1):44-9. PubMed ID: 25179964
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults.
Sun DL; Wang JH; Jiang B; Li LS; Li LS; Wu L; Wu HY; He Y
J Geriatr Cardiol; 2012 Jun; 9(2):123-9. PubMed ID: 22916057
[TBL] [Abstract][Full Text] [Related]
24. Age- and sex- specific all-cause mortality risk greatest in metabolic syndrome combinations with elevated blood pressure from 7 U.S. cohorts.
Yu WW; Randhawa AK; Blair SN; Sui X; Kuk JL
PLoS One; 2019; 14(6):e0218307. PubMed ID: 31194821
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach.
Santilli F; D'Ardes D; Guagnano MT; Davi G
Curr Med Chem; 2017; 24(24):2602-2627. PubMed ID: 28699503
[TBL] [Abstract][Full Text] [Related]
26. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
[TBL] [Abstract][Full Text] [Related]
27. Impaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome.
Onat A; Aydın M; Can G; Cakmak HA; Köroğlu B; Kaya A; Ademoğlu E
World J Diabetes; 2013 Oct; 4(5):210-8. PubMed ID: 24147205
[TBL] [Abstract][Full Text] [Related]
28. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
29. Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose Study.
Deravi N; Moazzeni SS; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
BMC Public Health; 2022 Sep; 22(1):1762. PubMed ID: 36114528
[TBL] [Abstract][Full Text] [Related]
30. Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients.
Pierdomenico SD; Pierdomenico AM; Di Tommaso R; Coccina F; Di Carlo S; Cuccurullo F; Porreca E
Am J Hypertens; 2016 Mar; 29(3):365-71. PubMed ID: 26224400
[TBL] [Abstract][Full Text] [Related]
31. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors.
Hadaegh F; Hasheminia M; Lotfaliany M; Mohebi R; Azizi F; Tohidi M
PLoS One; 2013; 8(9):e76304. PubMed ID: 24086723
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
34. Increased medical costs in elders with the metabolic syndrome are most evident with hospitalization of men.
Chang YH; Chen RC; Lee MS; Wahlqvist ML
Gend Med; 2012 Oct; 9(5):348-60. PubMed ID: 23000153
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.
Kurotani K; Miyamoto T; Kochi T; Eguchi M; Imai T; Nishihara A; Tomita K; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Nagahama S; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Sasaki N; Hori A; Nishiura C; Kuwahara K; Kuroda R; Akter S; Kashino I; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
J Epidemiol; 2017 Sep; 27(9):408-412. PubMed ID: 28434837
[TBL] [Abstract][Full Text] [Related]
36. Risk of cardiovascular events in patients with metabolic syndrome: Results of a population-based prospective cohort study (PURE Turkey).
Oğuz A; Kılıçkap M; Güleç S; Altuntaş Y; Karşıdağ K; Temizhan A; Tümerdem BÇ; Keskinler MV; Rangarajan S; Yusuf S
Anatol J Cardiol; 2020 Sep; 24(3):192-200. PubMed ID: 32870166
[TBL] [Abstract][Full Text] [Related]
37. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.
Michalsen VL; Wild SH; Kvaløy K; Svartberg J; Melhus M; Broderstad AR
BMC Cardiovasc Disord; 2021 Oct; 21(1):510. PubMed ID: 34674643
[TBL] [Abstract][Full Text] [Related]
38. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
Ding C; Yang Z; Wang S; Sun F; Zhan S
Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study.
Mozaffarian D; Kamineni A; Prineas RJ; Siscovick DS
Arch Intern Med; 2008 May; 168(9):969-78. PubMed ID: 18474761
[TBL] [Abstract][Full Text] [Related]
40. Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan.
Lai YJ; Yen YF; Chen LJ; Hsu LF; Ahmadi MN; Inan-Eroglu E; Ku PW; Stamatakis E
Diabetes Metab; 2023 May; 49(3):101415. PubMed ID: 36563960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
